December 27, 2014 6:13 PM ET


Company Overview of Speedel Pharma AG

Company Overview

Speedel Pharma AG was acquired by Novartis AG. Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. The company was founded in 1998 and is based in Basel, Switzerland.

Hirschgässlein 11

Basel,  4051


Founded in 1998


41 61 206 40 00


41 61 206 40 01

Key Executives for Speedel Pharma AG

Speedel Pharma AG does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
EffRx Pharmaceuticals SA Europe
ADD Advanced Drug Delivery Technologies AG Europe
CRINA S.A. Europe
Glenmark Pharmaceuticals S.A Europe
Novartis Pharma Schweiz AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Speedel Pharma AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at